July 11 (Reuters) - Drugmaker Eli Lilly and Co said on Thursday Christi Shaw, president of its bio-medicines business, would leave the company at the end of next month.
   Patrik Jonsson, general manager of Lilly Japan, will succeed Shaw, who served previously as president of Novartis USA and the North America head of Novartis Oncology.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Maju
Samuel)
((manojna.kalyani@thomsonreuters.com; within the U.S. +1 646
223 8780, outside the U.S. +91 80 6749 1692; Reuters Messaging:
manojna.kalyani.thomsonreuters.com@reuters.net)